C
CoMind
Non-invasive neuro-monitoring devices to enable bedside access to previously inaccessible brain signals
About CoMind
CoMind is a pioneering company in the field of neurotechnology, focusing on the development of advanced neuromonitoring devices and neural interfaces. These technologies aim to revolutionize patient care by providing doctors with access to a wide range of critical neurophysiological signals that are currently difficult to measure. The company serves healthcare providers, particularly those specializing in neurology and brain disorders, by offering non-invasive solutions that optimize patient outcomes across the care continuum.
Operating in the healthcare and medical devices market, CoMind employs a business model centered around the research, development, and commercialization of its innovative products. Revenue is generated through the sale of these neuromonitoring devices to hospitals, clinics, and research institutions globally. The company also collaborates with medical professionals and institutions to ensure the practical application and continuous improvement of its technologies.
CoMind's team comprises experts in non-invasive neuroimaging, neuroscience, and biomedical engineering, all committed to advancing the field of neurotechnology. The company is dedicated to fostering an inclusive environment that promotes collaboration and idea sharing across multiple disciplines, driving innovation and impactful product development.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- London, United Kingdom
- Employees
- 81
- Open positions
- 22
- Dealroom signal
- 92.6/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Biomarkers, Neurology, Core AI, Non-Invasive medical devices and treatments, Health Diagnostics
- Technology
- Artificial Intelligence, Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Oct 2025 | $60M | $240M | Latitude · Angelini Ventures · LocalGlobe · Crane Venture Partners | ↗ |
| SERIES AOther financing | Nov 2023 | $27M | $108M | Octopus Ventures · Angelini Ventures | ↗ |
Growth signals
Latest recorded traffic for CoMind is 10K monthly website visits, up 47.1% over the last three months. CoMind's team grew 11% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A6 investors entered at this stage
Angelini Ventures
Plural
Latitude
LocalGlobe
Crane Venture Partners- LPLord David Prior
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about CoMind on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CoMind’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.